Abstract

Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2017 - Volume 21, Number 6

Page(s): 494

Download in electronic PDF format for $75
  • Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Page 1

Abstract

A formulation for preparing Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • hydroxychloroquine sulfate
  • malaria
  • antimalarial agent
  • systemic lupus erythematosus
  • SLE
  • rheumatoid arthritis
  • autoimmune disorders
  • immune disorders

Related Categories

  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • INFECTIOUS DISEASE
  • MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2017
Pg. 494
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 316
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 66
Hydroxychloroquine Sulfate 200-mg Capsules
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 251-254
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes
Author(s): McHenry Adam R, Wempe Michael F, Rice Peter J
Nov/Dec 2021
Pg. 505
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2018
Pg. 54
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 415
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 416
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 235
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2024
Pg. 408-412
Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF
Author(s): Friciu Mihaela, Cull Erica, Leclair Grégoire
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 412
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 321
Neomycin Sulfate 25-mg/mL Oral Solution
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John